Keyword: oncology

News

Sun Pharma to Acquire Checkpoint Therapeutics

11.03.2025 -

Indian generic drug maker Sun Pharma agreed to acquire US immunotherapy and targeted oncology company Checkpoint Therapeutics for an upfront value of $355 million. The...

News

Jazz Pharmaceuticals to Acquire Chimerix for $935 Million

07.03.2025 -

Ireland’s Jazz Pharmaceuticals signed an agreement to acquire its compatriot Chimerix for approximately $935 million. The transaction is expected to close in the second...

News

Galapagos Intents to Split into Two Publicly Traded Entities

10.01.2025 -

Galapagos, a biotechnology company headquartered in Belgium, plans to split into two entities: a newly formed company (name to be announced at a later date) that will...

News

GSK May Acquire Cancer Specialist IDRx for $1 Billion

09.01.2025 -

In a move to expand its oncology business, GSK is nearing a $1 billion deal to buy a US biotech developing a treatment for rare gastrointestinal tumors.

News

Dren Bio, Novartis to Develop Bispecific Cancer Antibodies

26.07.2024 -

US biopharmaceutical company Dren Bio, a developer of novel antibody therapeutics, has entered into a collaboration with Novartis Pharma, a subsidiary of Novartis. The...

News

Novartis Acquires Morphosys for €2.7 Billion in Cash

06.02.2024 -

Novartis recently announced its agreement to acquire Morphosys AG, a Germany-based biopharmaceutical company specializing in oncology medicines. This strategic move...

News

Merck & Co. to Acquire Harpoon Therapeutics for $680 Million

09.01.2024 -

US Merck & Co., known as MSD outside of North America, intends to buy cancer drug developer Harpoon Therapeutics for $23.00 per share in cash for an approximate equity...

News

AstraZeneca to Buy Cell Therapy Developer Gracell for Up to $1.2 Billion

03.01.2024 -

AstraZeneca has agreed to acquire Gracell Biotechnologies, a Chinese developer of cell therapies for the treatment of cancer and autoimmune diseases, for up to $1.2...